कृपया अन्य खोज का प्रयास करें
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. The company offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, as well as cystinuria. It also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Charlotte E. Sibley | 78 | 2018 | Independent Director |
Elena Levtchenko | - | - | Member of Scientific Advisory Board |
André Ulmann | 75 | 2020 | Chief Medical Officer & Non-Voting Director |
Philippe Boucheron | 58 | 2011 | Chairman of the Board |
Catherine Dunand | 64 | 2017 | Director |
Thibaut Roulon | 48 | 2011 | Director |
Bertrand Knebelmann | - | - | Member of Scientific Advisory Board |
Laurent Cassedanne | 57 | 2021 | Deputy CEO, Deputy GM & Head Pharmacist and Director |
Gema Ariceta | - | - | Member of Scientific Advisory Board |
Larry Greenbaum | - | - | Member of Scientific Advisory Board |
Detlef Bockenhauer | - | 2019 | Member of Scientific Advisory Board |
Didier Laurens | 58 | 2021 | CEO, MD, General Director & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है